CellCarta has secured exclusive global rights to deploy Biofidelity’s Aspyre Lung assay in lung cancer clinical trials, streamlining genomic testing for trial sponsors and reducing reliance on multiple vendors.
A multicenter trial published in Clinical Chemistry reports Vitestro’s autonomous phlebotomy system achieved a 94.5% first-stick success rate, with low hemolysis and adverse event rates, in routine clinical settings.
The system offers faster run times and reduced sample consumption for the analysis of viral vectors, protein aggregates, and advanced materials.
Cenevo has launched the Labguru Customer Portal, a digital platform that integrates with ELN and LIMS systems to centralize workflows and provide real-time project visibility for CROs, CDMOs, and diagnostic labs.
The tool uses digitized pathology slides to estimate how patients will respond to therapy before surgery.
